Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis (Q37169576)

18 August 2017

0 references

Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis (English)

1 reference

18 August 2017

0 references

0 references

1 reference

4

Deborah Blacker

1 reference

18 August 2017

5

Dennis J Selkoe

1 reference

18 August 2017

2

Olivia I Okereke

1 reference

18 August 2017

6

Francine Grodstein

1 reference

18 August 2017

Alain Koyama

1

1 reference

18 August 2017

Ting Yang

series ordinal

3

1 reference

18 August 2017

language of work or name

1 reference

1 July 2012

1 reference

18 August 2017

Archives of Neurology

1 reference

18 August 2017

69

1 reference

18 August 2017

7

1 reference

18 August 2017

824-831

1 reference

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

New developments in the diagnosis of dementia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Ten-year change in plasma amyloid beta levels and late-life cognitive decline

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Performance characteristics of plasma amyloid-beta 40 and 42 assays

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Bias in meta-analysis detected by a simple, graphical test

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Meta-analysis in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

2010 Alzheimer's disease facts and figures

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Selective Reductions in Plasma A 1-42 in Healthy Elderly Subjects During Longitudinal Follow-Up: A Preliminary Report

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3772635

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22451159

12 December 2020

inferred from PubMed ID database lookup

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22451159

12 December 2020

inferred from PubMed ID database lookup

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22451159

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1001/ARCHNEUROL.2011.1841

1 reference

release_zzbg2aj3b5a2lj4mxscbcstrs4

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zzbg2aj3b5a2lj4mxscbcstrs4

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

1 reference